Tampa, FL, United States of America

Gary Reuther

This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., Incyte Corporation, University of South Florida. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Reuther. Retrieved from https://idiyas.com/inventor/gary-reuther-6lanuhkz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2026

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gary Reuther

Introduction

Gary Reuther is a prominent inventor based in Tampa, Florida, known for his significant contributions to the field of cancer research. With a total of six patents to his name, Reuther has made strides in developing compounds that target specific cancer pathways.

Latest Patents

Among his latest patents are the BRD4-JAK2 inhibitors. These patents disclose compounds that act as inhibitors of BDR4 and detail their application in cancer treatment. The patents also include methods for screening selective inhibitors of BDR4, showcasing compounds of various formulas.

Career Highlights

Reuther has had a notable career, working with esteemed organizations such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and Incyte Corporation. His work has focused on innovative approaches to cancer treatment, contributing to advancements in medical research.

Collaborations

Throughout his career, Reuther has collaborated with several professionals in the field, including Ernst Schönbrunn and Nicholas James Lawrence. These collaborations have further enhanced his research and development efforts.

Conclusion

Gary Reuther's work in developing BRD4-JAK2 inhibitors and his collaborations with leading researchers highlight his commitment to advancing cancer treatment. His contributions continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…